Surgical treatment of intracranial hypertension in encephalic cryptococcosis

British Journal of Neurosurgery

Volumn 17, Issue 5, 2003, Pages 450-455

  Calvo, A ^a   Hernandez P ^a   Spagnuolo, E ^a   Johnston, E ^a  

^a HOSPITAL MACIEL   (Uruguay)

Author keywords

Acquired Immunodeficiency Syndrome; Encephalic cryptococcosis; Intracranial hypertension; Ventriculoperitoneal shunt

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

CEREBROSPINAL FLUID CYTOLOGY; CLINICAL TRIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE COURSE; HUMAN; INTRACRANIAL HYPERTENSION; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; EMERGENCIES; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MENINGITIS, CRYPTOCOCCAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VENTRICULOPERITONEAL SHUNT;

EID: 10744229526     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690310001611242     Document Type: Review

References (29)

1. Caldemeyer K, Mathews V, Edwards-Brown M. Central nervous system cryptococcosis: parenchymal calcifications and large gelatinous pseudocysts. Am J Neurol Res 1997; 18:107-9.
2. Notling S, Fewgeler K. Medical mycology, 3rd edn. Berlin-New York: Springer Verlag, 1987.
3. Fernández-Concepción O, Ariosa-Acuña MC, Giroud-Benítez JL. Cryptococosis del Sistema Nervioso Central. Rev Neurol (Española) 2000;30:935-8.
4. Khanna N, Chandramuki A, Desai A. Cryptococcal infection of the central nervous system. J Med Microbiol 1996;45:376-9.
5. Po-Chou Liliang, Cheng-Long Liang, Wen-Neng Chang, Kang Lu, Cheng-Hsien Lu. Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus. (1997) Available at: http://www.uchicago.edu/CID/journal/ issues/v34n12/011398/ 11398.text.html
6. Prevett M, Plant G. Intracranial hypertension and HIV associated meningoradiculitis. J Neurol Neurosurg Psychiatry 1997;62:407-9.
7. Calvo, A. Consecuencias del SIDA sobre el sistema nervioso. In: Calvo A. (ed). Temas de Neurología. Montevideo: Librería Médica Editorial. 1990: 109-25.
8. Rosenblum ML, Levy RM, Bredesen DE. AIDS and nervous system. New York, Raven Press, 1988.
9. Bach M, Tally P, Godofsky E. Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997;41:1280-3.
10. Levy RM, Bredesen DE, Rosenblum ML. Opportunistic central nervous system pathology in patients with AIDS. Ann Neurol 1988;23(Suppl):S7-12.
11. Chan K, Mann K, Yue C. Neurosurgical aspects of cerebral cryptococcosis. Neurosurgery 1989;25:44-8.
12. Malessa R, Krams M, Hengge U. Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clin Invest 1994;72:1020-6.
13. Diamond RD, Bennet JE. Prognostic factors in cryptococcal meningitis and acquired immunodeficiency syndrome. Ann Int Med 1974;80:176-81.
14. Megson N, Stevens D, Hamilton J. D-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. J Clin Microbiol 1996;34:218-21.
15. Niehaus W, Flynn T. Regulation of mannitol biosynthesis and degradation by cryptococcus neoformans. J Bacteriol 1994; 176:651-5.
16. Wong B, Perfect J, Beggs S. Production of the hexitol D-mannitol by cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun 1990;58:1664-70.
17. Hakim CA, Hakim R, Hakim S. Normal-pressure hydrocephalus. Neurosurg Clin N Am 2001;36:761-73.
18. Denning D, Armstrong R, Lewis B. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91:267-72.
19. Li V. Methods and complications in surgical cerebrospinal fluid shunting. Neurosurg Clin N Am 2001;36:685-93.
20. Bayston R. Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections. Neurosurg Clin N Am 2001;36:703-8.
21. Ofory-Kwakye S, Wang A, Morris J. Septation and focal dilatation of ventricles associated with cryptococcal meningoencephalitis. Surg Neurol 1986;25:253-60.
22. Vender J, Miller D, Roth T. Intraventricular cryptococcal cyst. Am J Neurol Res 1996;17:110-13.
23. Saag MS, Graybill R, Larsen R. Practice guideline for the management of cryptococcal disease. Clin Infect Dis 2000; 30(4):710-18.
24. Saag MS, Cloud GA, Graybill R. A comparison of Itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999; 28:291-6.
25. Van der Horst CM, Saag MS, Cloud GA, Hamil R. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
26. de Gans J, Portegies P, Tiessens G. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
27. Leenders AC, Reiss P, Portegies P. Liposomal amphotericin B compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 1997;11:1463-71.
28. Rex J, Larsen R, Dismukes W. Catastrophic visual loss due to cryptococcus neoformans meningitis. Medicine 1993;72:207-24.
29. Rosenblum ML, Levy RM, Bredesen DE. Neurosurgical implications of the Acquired Immunodeficiency Syndrome (AIDS). Clin Neurosurg 1987;34:419-45.